Get Involved Bringing Joy to the Pediatric Ward Students Lara Jabbour and Nazanin Nayeri work to cheer up hospital staff and patients. by Bradley Jones Survivor Profile Breaking Down Barriers Cancer researcher Vicky Forster draws from her own experience with childhood leukemia to emphasize patient voices in cancer research. by Bradley Jones Should All Kids With Cancer Get Genetic Testing? Testing children with cancer for hereditary mutations could impact their treatment and provide information relevant to other family members. by Marcus A. Banks Understanding How Radiation Causes Cancer Researchers are investigating who is at greatest risk for radiation-induced cancers. by Kate Yandell Chemobrain: It’s Not Your Imagination Scientists discussed the mechanisms of chemotherapy-related cognitive impairment at a session dedicated to symptom science at the AACR Annual Meeting 2021. by Marci A. Landsmann A Drive for Diversity African Americans are underrepresented in the Be The Match bone marrow donor registry. Patient advocates are working to change that. by Jon Kelvey Get Involved Smiling Faces Rich Nardiello seeks to bring a smile to children with cancer. by Bradley Jones Pediatric Oncologists Underestimate Needs of Minority Parents Research describes how communication gaps can shift extra burden to parents who are members of ethnic and racial minority groups. by Marci A. Landsmann Advocacy in Action Leaving a Legacy Two mothers, each with a son who died of brain cancer, worked together to increase awareness and acceptance of tumor tissue donation. by Esther Landhuis A Unified Strategy A couple who lost their daughter to brain cancer builds a charity that connects parents, hospitals and researchers with data. by Marci A. Landsmann next Cancer Talk Remote Care After adapting remote patient monitoring programs to cancer patients with COVID-19, cancer centers delve deeper into the programs’ value for cancer patients undergoing treatment. by Jon Kelvey Moving Away From the Maximum Tolerated Dose The FDA recently expressed a new commitment to testing cancer drugs at lower doses, rather than defaulting to the highest dose most people can tolerate. by Marcus A. Banks The Individual Sphere of Influence Can discussion of health inequities lead to actionable change? by Marci A. Landsmann A Treatment That Came Just in Time Cancer survivor Laurie Adami reflects on her experience participating in a clinical trial that ultimately contributed to the March 2021 approval of a CAR-T cell therapy for follicular lymphoma. by Laurie Adami More Posts